Autologous transplant bloodstream transplanted. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Transplants Blood T-Lymphocytes Cells, Cultured T-Lymphocytes, Cytotoxic Antilymphocyte Serum Kidney Dendritic Cells Lymphocytes Hematopoietic Stem Cells CD4-Positive T-Lymphocytes Leukocytes, Mononuclear Bone Marrow Bone Marrow Cells Platelet-Rich Plasma CD8-Positive T-Lymphocytes Clone Cells Monocytes Killer Cells, Natural T-Lymphocytes, Regulatory Liver Autografts

Organisms25

Trypanosoma brucei brucei Candida Candida glabrata Life Cycle Stages Blood-Borne Pathogens Trypanosoma Tsetse Flies Trypanosoma congolense Gram-Negative Bacteria Cytomegalovirus Trypanosoma lewisi Gram-Positive Bacteria Enterococcus Staphylococcus aureus BK Virus Mice, Inbred C57BL Methicillin-Resistant Staphylococcus aureus Trypanosoma brucei gambiense Mice, Inbred BALB C Klebsiella pneumoniae Candida albicans Transplantation Chimera Bacteria Rabbits Trypanosoma cruzi

Diseases48

Hodgkin Disease Multiple Myeloma Recurrence Bacteremia Fungemia Catheter-Related Infections Cross Infection Candidemia Candidiasis Trypanosomiasis, African Postoperative Complications Gram-Negative Bacterial Infections Sepsis Gram-Positive Bacterial Infections Cytomegalovirus Infections Graft vs Host Disease Trypanosomiasis Hematologic Neoplasms Staphylococcal Infections Lymphoma, Non-Hodgkin Mycoses Cadaver Opportunistic Infections Kidney Failure, Chronic Liver Failure Acute Disease Infection Neoplasms Bronchiolitis Obliterans Neutropenia Leukemia Lymphoproliferative Disorders Bacterial Infections Klebsiella Infections Disease Models, Animal Fever Leukemia, Myeloid, Acute Lymphoma Kidney Diseases Melanoma Liver Diseases Polyomavirus Infections Serratia Infections Hematologic Diseases Enterobacteriaceae Infections End Stage Liver Disease Community-Acquired Infections Chronic Disease

Chemicals and Drugs42

Immunosuppressive Agents Variant Surface Glycoproteins, Trypanosoma Cyclosporine Tacrolimus Anti-Bacterial Agents Antifungal Agents Melphalan Cyclophosphamide Aconitic Acid Protozoan Proteins Mycophenolic Acid HLA Antigens Carmustine Trypanocidal Agents Antibodies, Monoclonal Etoposide Antilymphocyte Serum RNA, Protozoan Antigens, CD34 Busulfan Thiotepa Antigens, Neoplasm Fluconazole Vancomycin Isoantibodies Cancer Vaccines Cytarabine Granulocyte Colony-Stimulating Factor Ganciclovir Myeloablative Agonists Antigens, CD Interleukin-2 Prednisone Biological Markers Creatinine Anti-Infective Agents Immunoglobulin G Recombinant Proteins Vincristine Isoantigens Antiviral Agents DNA, Kinetoplast

Analytical, Diagnostic and Therapeutic Techniques and Equipment81

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Transplantation Conditioning Hematopoietic Stem Cell Mobilization Treatment Outcome Retrospective Studies Survival Analysis Kidney Transplantation Blood Transfusion, Autologous Catheterization, Central Venous Heart Transplantation Transplantation Lung Transplantation Stem Cell Transplantation Catheters, Indwelling Immunosuppression Combined Modality Therapy Risk Factors Prospective Studies Follow-Up Studies Histocompatibility Testing Microbial Sensitivity Tests Peripheral Blood Stem Cell Transplantation Fetal Tissue Transplantation Survival Rate Whole-Body Irradiation Bone Marrow Purging Antineoplastic Combined Chemotherapy Protocols Incidence Lymphocyte Culture Test, Mixed Microbiological Techniques Cell Transplantation Lymphocyte Activation Cohort Studies Prognosis Salvage Therapy Disease-Free Survival Heart-Lung Transplantation Transplantation, Heterotopic Brain Tissue Transplantation Flow Cytometry Polymerase Chain Reaction Remission Induction Transplantation, Isogeneic Fatal Outcome Multivariate Analysis Biopsy Immunotherapy, Adoptive Cell Separation Tissue Transplantation Mycological Typing Techniques Immunotherapy Central Venous Catheters Bone Transplantation Disease Models, Animal Kaplan-Meier Estimate Islets of Langerhans Transplantation Renal Dialysis Vascular Access Devices Blood Transfusion Feasibility Studies Risk Assessment Postoperative Period Leukapheresis Skin Transplantation Drug Therapy, Combination Tissue and Organ Harvesting Case-Control Studies Proportional Hazards Models Treatment Failure Immunophenotyping Coculture Techniques Cord Blood Stem Cell Transplantation Cytotoxicity Tests, Immunologic Electrophoresis, Gel, Pulsed-Field Reoperation Sensitivity and Specificity Predictive Value of Tests Actuarial Analysis

Phenomena and Processes17

Graft Rejection Graft Survival Time Factors Immunocompromised Host Transplantation Immunology Cytotoxicity, Immunologic Life Cycle Stages Drug Resistance, Fungal Lymphocyte Activation Histocompatibility Transplantation Tolerance Vancomycin Resistance Cell Differentiation Genes, Protozoan Drug Resistance, Bacterial Amino Acid Sequence Sensitivity and Specificity

Information Science5

Survival Rate Incidence Molecular Sequence Data Fatal Outcome Amino Acid Sequence

Named Groups3

Tissue Donors Living Donors Infant, Newborn

Health Care31

Treatment Outcome Retrospective Studies Survival Analysis Tissue and Organ Procurement Equipment Contamination Risk Factors Prospective Studies Waiting Lists Follow-Up Studies Survival Rate Infection Control Incidence Cohort Studies Disease-Free Survival Intensive Care Units Hospitals, University Fatal Outcome Multivariate Analysis Kaplan-Meier Estimate Drug Contamination Feasibility Studies Risk Assessment Postoperative Period Directed Tissue Donation Case-Control Studies Proportional Hazards Models Treatment Failure Hospitals Sensitivity and Specificity Predictive Value of Tests Actuarial Analysis

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care Geographicals

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Transplantation Conditioning Hematopoietic Stem Cell Mobilization Hodgkin Disease Multiple Myeloma Recurrence Treatment Outcome Retrospective Studies Bacteremia Survival Analysis Kidney Transplantation Trypanosoma brucei brucei Blood Transfusion, Autologous Fungemia Transplants Graft Rejection Catheter-Related Infections Graft Survival Catheterization, Central Venous Immunosuppressive Agents Heart Transplantation Cross Infection Tissue Donors Transplantation Time Factors Blood Lung Transplantation Candidemia Candidiasis Variant Surface Glycoproteins, Trypanosoma Stem Cell Transplantation Candida Trypanosomiasis, African Postoperative Complications Tissue and Organ Procurement Catheters, Indwelling Cyclosporine Immunosuppression Combined Modality Therapy Tacrolimus Living Donors Equipment Contamination Immunocompromised Host Risk Factors Anti-Bacterial Agents Gram-Negative Bacterial Infections Prospective Studies Sepsis Waiting Lists Antifungal Agents Melphalan Follow-Up Studies Gram-Positive Bacterial Infections Cytomegalovirus Infections T-Lymphocytes Histocompatibility Testing Graft vs Host Disease Microbial Sensitivity Tests Peripheral Blood Stem Cell Transplantation Fetal Tissue Transplantation Trypanosomiasis Hematologic Neoplasms Transplantation Immunology Cyclophosphamide Staphylococcal Infections Survival Rate Whole-Body Irradiation Aconitic Acid Protozoan Proteins Lymphoma, Non-Hodgkin Bone Marrow Purging Mycophenolic Acid Candida glabrata Mycoses Infection Control Antineoplastic Combined Chemotherapy Protocols Cadaver Incidence Opportunistic Infections Lymphocyte Culture Test, Mixed Kidney Failure, Chronic Microbiological Techniques Cells, Cultured HLA Antigens Cytotoxicity, Immunologic Life Cycle Stages Blood-Borne Pathogens Carmustine Cell Transplantation Drug Resistance, Fungal Liver Failure Lymphocyte Activation Trypanocidal Agents Cohort Studies Prognosis T-Lymphocytes, Cytotoxic Trypanosoma

No FAQ available that match "autologous transplant bloodstream transplanted"